Pipeline

Pipeline

Overview

The Kyn Therapeutics pipeline addresses distinct immuno-metabolic targets. Each of these programs targets key metabolites in highly characterized pathways that drive immunosuppression in numerous cancer types.

Pipeline

1 Pembrolizumab provided through a supply agreement with Merck.
2 Celgene has exclusive options under a global strategic collaboration agreement.

Contact us

Find us

Kyn Therapeutics
50 Northern Avenue
7th Floor
Boston, MA 02210

Call us

1-857-273-8343

Email us

info@kyntherapeutics.com

Friend us

LinkedIn